Indication
Cutis Laxa Facialis
1 clinical trial
1 product
Clinical trial
A Phase IV Open-label Trial Assessing the Impact on Skin Quality, Hydration, and Barrier of Three (3) Hydrafacial Treatments in Adults of Fitzpatrick Skin Types I-VIStatus: Not yet recruiting, Estimated PCD: 2024-05-01
Product
ReGen-GF